These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 11573654)

  • 1. A breakthrough in the genetic diagnosis of malignant hyperthermia.
    Robinson RL; Hopkins PM
    Br J Anaesth; 2001 Feb; 86(2):166-8. PubMed ID: 11573654
    [No Abstract]   [Full Text] [Related]  

  • 2. Genomic Screening for Malignant Hyperthermia Susceptibility.
    Biesecker LG; Dirksen RT; Girard T; Hopkins PM; Riazi S; Rosenberg H; Stowell K; Weber J
    Anesthesiology; 2020 Dec; 133(6):1277-1282. PubMed ID: 32898259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Guidelines for molecular genetic detection of susceptibility to malignant hyperthermia.
    Urwyler A; Deufel T; McCarthy T; West S;
    Br J Anaesth; 2001 Feb; 86(2):283-7. PubMed ID: 11573677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Malignant hyperthermia genetic testing in North America Working Group Meeting. Bethesda, Maryland. September 4-5, 2002.
    Sei Y; Sambuughin N; Muldoon S
    Anesthesiology; 2004 Feb; 100(2):464-5. PubMed ID: 14870754
    [No Abstract]   [Full Text] [Related]  

  • 5. Genetics and susceptibility to malignant hyperthermia.
    Anderson-Pompa K; Foster A; Parker L; Wilks L; Cheek DJ; Mill TD; Dore M; McSherry G
    Crit Care Nurse; 2008 Dec; 28(6):32-6; quiz 37. PubMed ID: 19047693
    [No Abstract]   [Full Text] [Related]  

  • 6. A genetic mystery in malignant hyperthermia 'solved'?
    Schiemann AH; Bjorksten AR; Gillies RL; Hockey BM; Ball C; Pollock N; Bulger T; Stowell KM
    Br J Anaesth; 2018 Sep; 121(3):681-682. PubMed ID: 30115273
    [No Abstract]   [Full Text] [Related]  

  • 7. European Malignant Hyperthermia Group guidelines for investigation of malignant hyperthermia susceptibility.
    Hopkins PM; Rüffert H; Snoeck MM; Girard T; Glahn KP; Ellis FR; Müller CR; Urwyler A;
    Br J Anaesth; 2015 Oct; 115(4):531-9. PubMed ID: 26188342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Scientific advances in the genetic understanding and diagnosis of malignant hyperthermia.
    Hernandez JF; Secrest JA; Hill L; McClarty SJ
    J Perianesth Nurs; 2009 Feb; 24(1):19-31; quiz 32-4. PubMed ID: 19185818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Malignant hyperthermia: how important after 30 years.
    Ellis FR
    Acta Anaesthesiol Belg; 1990; 41(2):61-3. PubMed ID: 2371806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular genetic testing to diagnose malignant hyperthermia susceptibility.
    Girard T; Litman RS
    J Clin Anesth; 2008 May; 20(3):161-3. PubMed ID: 18502356
    [No Abstract]   [Full Text] [Related]  

  • 11. The genetic basis of malignant hyperthermia.
    Greenbaum I; Weigl Y; Pras E
    Isr Med Assoc J; 2007 Jan; 9(1):39-41. PubMed ID: 17274355
    [No Abstract]   [Full Text] [Related]  

  • 12. Malignant hyperthermia: advances in clinical management and diagnosis.
    Hopkins PM
    Br J Anaesth; 2000 Jul; 85(1):118-28. PubMed ID: 10928000
    [No Abstract]   [Full Text] [Related]  

  • 13. [The investigation of malignant hyperthermia susceptibility].
    Glahn KP
    Ugeskr Laeger; 2016 May; 178(18):. PubMed ID: 27137116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Malignant hyperthermia as a complication of anesthesia: predisposition is hereditary].
    Snoeck MM; Gielen MJ; Sengers RC; Padberg GW; Iles DE; Booij LH
    Ned Tijdschr Geneeskd; 1997 Mar; 141(13):616-9. PubMed ID: 9190536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of malignant hyperthermia in France: Current organisation.
    Julien Marsollier F; Roux-Buisson N; Dalmas AF; Bruneau B; Dahmani S
    Anaesth Crit Care Pain Med; 2019 Oct; 38(5):535. PubMed ID: 30807880
    [No Abstract]   [Full Text] [Related]  

  • 16. How carefully can we phenotype patients suspected of malignant hyperthermia susceptibility?
    Larach MG; MacLennan DH
    Anesthesiology; 1999 Mar; 90(3):645-8. PubMed ID: 10078661
    [No Abstract]   [Full Text] [Related]  

  • 17. A rare genetic variant of the ryanodine receptor in a suspected malignant hyperthermia susceptible patient.
    MacKay EJ; Wilkerson C; Kraeva N; Rosenberg H; Kennedy T
    J Clin Anesth; 2016 Sep; 33():144-6. PubMed ID: 27555149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Malignant hyperthermia: turn down the heat.
    Mitchell-Brown F
    Nursing; 2012 May; 42(5):38-44; quiz 44-5. PubMed ID: 22488207
    [No Abstract]   [Full Text] [Related]  

  • 19. AANA Journal course: update for nurse anesthetists--genetic testing for malignant hyperthermia.
    Curtis S
    AANA J; 1996 Dec; 64(6):557-62. PubMed ID: 9204791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent advances in the diagnosis of malignant hyperthermia susceptibility: how confident can we be of genetic testing?
    Robinson RL; Anetseder MJ; Brancadoro V; van Broekhoven C; Carsana A; Censier K; Fortunato G; Girard T; Heytens L; Hopkins PM; Jurkat-Rott K; Klinger W; Kozak-Ribbens G; Krivosic R; Monnier N; Nivoche Y; Olthoff D; Rueffert H; Sorrentino V; Tegazzin V; Mueller CR
    Eur J Hum Genet; 2003 Apr; 11(4):342-8. PubMed ID: 12700608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.